Company Search:
Advanced Search
Sponsored Links
Clovis Oncology Inc Company Snapshot
Clovis Oncology Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clovis Oncology Inc with three other companies in this sector in UNITED STATES : Ligand Pharmaceuticals Inc (2020 sales of $186.42 million ), Agios Pharmaceuticals Inc ($203.20 million ), and ImmunoGen, Inc. ($132.30 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Clovis Oncology Inc
  Stock Performance Chart for Clovis Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/19/2021): 6.65
(Figures in U.S. Dollars)
1 Week -15.8%   13 Weeks -0.4%  
4 Weeks 57.2%   52 Weeks -39.5%  
Clovis Oncology Inc Key Data:
  Ticker: CLVS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 164,522,000
(Year Ending Jan 2021).
Employees: 484
  Currency: U.S. Dollars Market Cap: 587,255,296
  Fiscal Yr Ends: December Shares Outstanding: 88,309,067
  Share Type: Common Closely Held Shares: 1,888,304
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.